More Globe Newswire

View Older Stories View Newer Stories

Oct 23, 2024 07:30AM Context Therapeutics to Participate in Upcoming Investor Conferences in November
Oct 23, 2024 07:30AM Arbutus to Report Third Quarter 2024 Financial Results and Provide Corporate Update
Oct 23, 2024 07:22AM Jianzhi Education Technology Strengthens its EdTech Capabilities with AI
Oct 23, 2024 07:21AM Lloyds Bank PLC: 2024 Q3 Interim Management Statement
Oct 23, 2024 07:20AM EBC Financial Group and the University of Oxford’s Department of Economics Announce WERD Episode on Macroeconomics and Climate
Oct 23, 2024 07:19AM Landsbankinn hf.: Financial results of Landsbankinn for the first nine months of 2024
Oct 23, 2024 07:19AM UP Fintech Announces Pricing of Follow-on Public Offering of American Depositary Shares
Oct 23, 2024 07:16AM ROCKWOOL A/S – transactions in connection with share buy-back programme
Oct 23, 2024 07:15AM Kymera Therapeutics to Report Third Quarter 2024 Financial Results on October 31
Oct 23, 2024 07:12AM DIOS to pursue exploration of Heberto Gold discovery, Quebec
Oct 23, 2024 07:12AM MGA Entertainment Introduces Fraggle Rock: Back to the Rock Plush Line Under Little Tikes® Brand
Oct 23, 2024 07:10AM ShorePoint Showcases Resilient Cyber Defenses with ISO 27001:2022 Certification
Oct 23, 2024 07:05AM Modifi Biosciences Acquired by Merck
Oct 23, 2024 07:05AM Manhattan Bridge Capital, Inc. Reports Third Quarter 2024 Results
Oct 23, 2024 07:00AM HSBC Bank Plc - Form 8.5 (EPT/RI) - Learning Technologies Group plc
Oct 23, 2024 07:00AM Chicago Atlantic Real Estate Finance Closes on $50 Million Unsecured Term Loan to Fund Deployment of New Investments
Oct 23, 2024 07:00AM EvolveImmune Therapeutics to Present New Preclinical Data Highlighting Pipeline Progress for EVOLVE T Cell Engager Platform at 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
Oct 23, 2024 07:00AM Eccogene Receives Milestone Payment of $60 Million from AstraZeneca Following Dosing of the First Patient in Global Phase 2b Program of ECC5004/AZD5004 for the Treatment of Obesity and Type 2 Diabetes
Oct 23, 2024 07:00AM Nevada Lithium Achieves 97% Lithium and 98% Boron Recovery on High-Grade Mineralization. Engages Fluor Enterprises, Inc. to Design Flowsheet and Process Plant for Updated PEA
Oct 23, 2024 07:00AM Kymera Therapeutics Announces Three Scientific Presentations at the EORTC-NCI-AACR 2024 Symposium
Oct 23, 2024 07:00AM CFA Societies Canada announces 2024-2025 Board of Directors
Oct 23, 2024 07:00AM Stifel Reports Third Quarter 2024 Results
Oct 23, 2024 07:00AM Fidelity D & D Bancorp, Inc. Reports Third Quarter 2024 Financial Results
Oct 23, 2024 07:00AM Agios Completes Enrollment of Phase 3 RISE UP Study of Mitapivat in Sickle Cell Disease
Oct 23, 2024 07:00AM Monte Rosa Therapeutics Presents Preclinical Data at the 36th EORTC-NCI-AACR Symposium on the Potential of its Cyclin E1-directed Molecular Glue Degraders for the Treatment of CCNE1-Amplified Solid Tu
Oct 23, 2024 07:00AM Cogent Biosciences Announces Pipeline Expansion into KRAS and Poster Presentations at the 2024 EORTC-NCI-AACR International Symposium on Molecular Targets and Cancer Therapeutics
Oct 23, 2024 07:00AM Siyata Mobile to Present at The ThinkEquity Conference
Oct 23, 2024 07:00AM Solstice Commences Alpha IP Program at Strathy Gold Project, Abitibi Subprovince
Oct 23, 2024 07:00AM OKYO Pharma Announces First Patient Dosed in the First Clinical Trial to Treat Neuropathic Corneal Pain
Oct 23, 2024 07:00AM Perspective Therapeutics Presents Updates at the 37th Annual Congress of the European Association of Nuclear Medicine
Oct 23, 2024 07:00AM Winnebago Industries Reports Fourth Quarter and Full Year Fiscal 2024 Results
Oct 23, 2024 07:00AM Kaixin Holdings Announces Share Consolidation
Oct 23, 2024 07:00AM Telesat awards contract to Intellian to design and supply gateway antennas for the Telesat Lightspeed network
Oct 23, 2024 07:00AM TransCode Therapeutics Announces Safety Review Committee Approval of Second Cohort Opening in Phase 1 TTX-MC138 Clinical Trial Following Favorable Review of Cohort 1 Safety Data
Oct 23, 2024 07:00AM ORIC® Pharmaceuticals Presents Data Further Supporting Potential Best-In-Class Profile of ORIC-114 to Treat EGFR Exon 20 Insertions and Other Atypical Mutations at the EORTC-NCI-AACR Symposium on Mol
Oct 23, 2024 07:00AM Omni-Lite Industries to Offer Virtual Attendance for Annual Meeting
Oct 23, 2024 07:00AM Village Farms International to Report Q3/24 Results on November 7, 2024
Oct 23, 2024 07:00AM ScottsMiracle-Gro Announces Timing of Fourth Quarter 2024 Financial Results and Webcast
Oct 23, 2024 07:00AM Olema Oncology Presents Compelling New Preclinical Data Demonstrating Anti-Tumor Activity for OP-3136 with Enhanced Activity of Palazestrant Combinations at ENA 2024
Oct 23, 2024 07:00AM Starget Pharma and Cancer Focus Fund Announce $5.1 Million Investment to Support Phase 1b Clinical Trial of Novel Peptide Radioligand for Precision Cancer Therapy
Oct 23, 2024 07:00AM Talen Energy to Report Third Quarter 2024 Financial Results on November 12, 2024
Oct 23, 2024 07:00AM Creative Potential: New Study Reveals AI’s Role in Bridging the Gap Between Insights and Creative Impact
Oct 23, 2024 07:00AM Eyenovia Announces Publication of Study Demonstrating Favorable Impact on the Ocular Surface of Medication Delivered with the Optejet®
Oct 23, 2024 07:00AM Climb Channel Solutions Launches NA Partnership with Software Management Platform Vendor, FinQuery
Oct 23, 2024 07:00AM Katapult to Announce Third Quarter 2024 Financial Results on November 6, 2024
Oct 23, 2024 07:00AM Genenta’s CEO to present at the U.S. Senate meeting on “Cross-Border Investments and Strategies in the Biotechnology Sector: A Transatlantic Perspective”
Oct 23, 2024 06:57AM Dimensional Fund Advisors Ltd. : Form 8.3 - STONEX GROUP INC - Ordinary Shares
Oct 23, 2024 06:55AM YieldMax™ ETFs Announces Distributions on MSTY (175.64%), AIYY (100.45%), SQY (70.37%), YMAX (67.11%), YMAG (14.96%) and Others
Oct 23, 2024 06:55AM Roper Technologies announces third quarter financial results
Oct 23, 2024 06:54AM HSBC Bank Plc - Form 8.5 (EPT/RI) - Keywords Studios plc
View Newer Stories View Older Stories